UBS AG - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AG ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2014$2,538,000
-18.5%
72,467
-23.6%
0.00%0.0%
Q2 2014$3,115,000
-9.2%
94,795
+1.8%
0.00%
-33.3%
Q1 2014$3,432,000
+12.3%
93,144
+16.9%
0.00%0.0%
Q4 2013$3,057,000
+28.5%
79,666
-8.3%
0.00%
+50.0%
Q3 2013$2,379,000
+34.6%
86,834
+3.1%
0.00%0.0%
Q2 2013$1,768,00084,2190.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,762,017$64,948,0007.10%
Coupland Cardiff Asset Management LLP 261,361$9,634,0006.70%
Sloane Robinson LLP 160,100$5,901,0003.50%
Myriad Asset Management Ltd. 418,728$15,434,0003.07%
Granite Point Capital Management, L.P. 102,000$3,760,0002.69%
GRATRY & Co LLC 191,545$7,060,0002.54%
Consonance Capital Management LP 430,889$15,883,0002.36%
Grandeur Peak Global Advisors, LLC 263,135$9,699,0002.29%
Mirae Asset Global Investments Co., Ltd. 2,356,378$86,856,0002.20%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 91,460$3,371,0001.60%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders